NeuroBo Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2014 to Q3 2024.
  • NeuroBo Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.65M, a 48% decline year-over-year.
  • NeuroBo Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$27.7M, a 134% decline year-over-year.
  • NeuroBo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.5M, a 10.7% increase from 2022.
  • NeuroBo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14M, a 8.62% increase from 2021.
  • NeuroBo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$15.3M, a 48.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$27.7M -$5.65M -$1.83M -48% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$25.9M -$10.1M -$9.32M -1270% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$16.6M -$6.71M -$4.11M -158% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$12.5M -$5.31M -$638K -13.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$11.8M -$3.82M -$705K -22.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$11.1M -$734K +$2.57M +77.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$13.7M -$2.6M +$271K +9.43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$14M -$4.68M -$98K -2.14% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$13.9M -$3.11M +$348K +10.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$14.2M -$3.3M +$618K +15.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$14.8M -$2.88M +$449K +13.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$15.3M -$4.58M +$14.9M +76.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$30.2M -$3.46M -$407K -13.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$29.8M -$3.92M -$1.54M -64.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$28.3M -$3.32M +$1.41M +29.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$29.7M -$19.5M -$6.18M -46.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$23.5M -$3.05M +$567K +15.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$24.1M -$2.38M -$483K -25.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$23.6M -$4.73M -$2.27M -92% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$21.3M -$13.3M -$9.67M -264% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$11.6M -$3.62M +$2.46M +40.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$14.1M -$1.9M +$4.78M +71.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$18.9M -$2.46M +$4.76M +65.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$23.6M -$3.66M +$3.09M +45.8% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$26.7M -$6.08M +$2.59M +29.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$29.3M -$6.68M +$3.82M +36.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 -$33.1M -$7.22M +$272K +3.63% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 -$33.4M -$6.75M +$468K +6.49% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$33.9M -$8.67M -$4.79M -124% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$29.1M -$10.5M -$9.11M -655% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$20M -$7.5M -$5.39M -256% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$14.6M -$7.21M -$4.64M -181% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 -$9.94M -$3.88M -$1.31M -51% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-20
Q2 2016 -$8.63M -$1.39M +$220K +13.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-20
Q1 2016 -$8.85M -$2.1M +$176K +7.72% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-20
Q4 2015 -$9.03M -$2.57M -$2.37M -1211% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-21
Q3 2015 -$6.66M -$2.57M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-21
Q2 2015 -$1.61M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-21
Q1 2015 -$2.28M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-21
Q4 2014 -$196K Nov 1, 2014 Dec 31, 2014 10-K 2017-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.